Gonzalez D G, Schuster-Uitterhoeve A L
Cancer. 1983 Jun 1;51(11):2048-52. doi: 10.1002/1097-0142(19830601)51:11<2048::aid-cncr2820511115>3.0.co;2-t.
Primary non-Hodgkin's lymphoma (NHL) of the central nervous system is a rare disease. The number of cases reported in the literature does not exceed 200. The current series comprises 15 cases of primary NHL of the CNS. In 12 cases material for pathology was obtained at surgery. In the other three cases the diagnosis was established by cytologic examination of the cerebrospinal fluid (CSF). The type of lymphoma was predominantly the diffuse lymphocytic type. All the patients received irradiation on the whole brain by means of two opposite lateral fields. The administered total doses were 40 Gy in four weeks in ten cases, 50 to 60 Gy in 5 to 6 weeks in four cases and 30 Gy in three weeks in one case. All but three patients are dead although initially a good tumor response was obtained as confirmed in most of the cases by CT scan. The mean survival of the dead patients was 14.5 months. No relationship was found between the administered dose and the relapse-free time. In six cases (40%) evidence of seeding was observed. Because of the poor results obtained with irradiation either of only the tumor bearing area or whole brain and because of the high risk of seeding through the CSF, the irradiation of the entire CNS is recommended in patients with primary NHL of the brain.
原发性中枢神经系统非霍奇金淋巴瘤(NHL)是一种罕见疾病。文献报道的病例数不超过200例。本系列研究包括15例原发性中枢神经系统NHL。其中12例在手术时获取了病理材料。另外3例通过脑脊液(CSF)细胞学检查确诊。淋巴瘤类型主要为弥漫性淋巴细胞型。所有患者均通过两个相对的侧野对全脑进行照射。10例患者在4周内给予的总剂量为40 Gy,4例患者在5至6周内给予50至60 Gy,1例患者在3周内给予30 Gy。除3例患者外,所有患者均已死亡,尽管最初通过CT扫描证实大多数病例肿瘤反应良好。死亡患者的平均生存期为14.5个月。未发现给予的剂量与无复发生存时间之间存在关联。6例(40%)观察到播散证据。由于仅对肿瘤部位或全脑进行照射效果不佳,且通过脑脊液发生播散的风险较高,因此建议对原发性脑NHL患者照射整个中枢神经系统。